Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

New first-line ovarian cancer data: How this will impact first line and relapse treatment?

Presentation by Expert

Date

16 Sep 2024

Session

New first-line ovarian cancer data: How this will impact first line and relapse treatment?

Topics

Tumour Site

Ovarian Cancer

Presenters

Isabelle Ray-Coquard

Authors

I.L. Ray-Coquard

Author affiliations

  • Medical Oncology Department, Centre Léon Bérard, 69008 - Lyon/FR

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Discussion led by Chair

Presenter: Nicoletta Colombo

Session: New first-line ovarian cancer data: How this will impact first line and relapse treatment?

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.